Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism

European Respiratory Journal

Volumn 48, Issue 5, 2016, Pages 1360-1368

  Peris, Marisa ^a   Jiménez, David ^b   Maestre, Ana ^c   Font, Carme ^d   Tafur, Alfonso J ^e   Mazzolai, Lucia ^f   Xifre, Belén ^g   Skride, Andris ^h   Dentali, Francesco ⁱ   Monreal, Manuel ^j  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c Neurology Section   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g H El Vendrell   (Spain)

^h PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

ⁱ UNIVERSITY OF INSUBRIA   (Italy)

^j CATHOLIC UNIVERSITY OF MURCIA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CANCER PATIENT; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INCIDENTAL FINDING; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VENOUS THROMBOEMBOLISM; COMPLICATION; FIBRINOLYTIC THERAPY; MIDDLE AGED; NEOPLASM; REGISTER; RISK ASSESSMENT;

AGED; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASMS; PULMONARY EMBOLISM; REGISTRIES; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84994223663     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00779-2016     Document Type: Article

References (20)

1. Gosselin MV, Rubin GD, Leung AN, et al. Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. Radiology 1998; 208: 209-215.
2. Dentali F, Ageno W, Becattini C, et al. Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res 2010; 125: 518-522.
3. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of Chest Physician Evidence-Based Clinical Practices Guidelines. Chest 2012; 141: e419S-e494S.
4. Lyman G, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2189-2204.
5. den Exter PL, Hooijer J, Dekkers OM, et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011; 29: 2405-2409.
6. Shinagare AB, Okajima Y, Oxnard GR, et al. Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer 2012; 78: 161-166.
7. Douma RA, Kok MGM, Verberne LM, et al. Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res 2010; 125: e306-e309.
8. Engelke C, Rummeny EJ, Marten K. Pulmonary embolism at multi-detector row CT of chest: one-year survival of treated and untreated patients. Radiology 2006; 239: 563-575.
9. O'Connell CL, Boswell WD, Duddalwar V, et al. Unsuspected pulmonary emboli in cancer patients: Clinical correlates and relevance. J Clin Oncol 2006; 24: 1712-1719.
10. Gladish GW, Choe DH, Marom EM, et al. Incidental pulmonary emboli in oncology patients: Prevalence, CT evaluation, and natural history. Radiology 2006; 40: 246-255.
11. Cronin CG, Lohan DG, Keane M, et al. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. Am J Roentgenol 2007; 189: 162-170.
12. Browne AM, Cronin CG, English C, et al. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 2010; 5: 798-803.
13. Font C, Farrús B, Vidal L, et al. Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients. Ann Oncol 2011; 22: 2101-2106.
14. Soler S, Delgado C, Ballaz A, et al. Unsuspected pulmonary embolism in patients with cancer. Thromb Res 2012; 129 Suppl 1: S16-S19.
15. van der Hulle T, den Exter PL, Planquette B, et al. Risk of recurrent venous thromboembolism and major haemorrhage in cancer-associated incidental pulmonary embolism amongst treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost 2016; 14: 105-113.
16. Monreal M, Falgá C, Valdés M, et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: Findings from the RIETE Registry. J Thromb Haemost 2006; 4: 1950-1956.
17. Ruíz-Gimenez N, Suárez C, González R, et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26-31.
18. Nieto JA, Solano R, Ruíz-Ribó MD, et al. Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: Findings from the RIETE Registry. J Thromb Haemost 2010; 8: 1216-1222.
19. Laporte S, Mismetti P, Decousus H, et al. Clinical predictors for fatal pulmonary embolism in 15, 520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad Tromboembolica Venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716.
20. Khorana AA, O'Connell C, Agnelli G, et al. Incidental venous thromboembolism in oncology patients. J Thromb Haemost 2012; 10: 2602-2604.